Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A
KNSA
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.45B
Close$
$65.00
0.7% upsideKiniksa Pharmaceuticals International Plc. Target Price Details
Target Price by Analysts
0.7% upsideKiniksa Pharmaceuticals International Plc. Target Price Details$-4.53
107% downside
Current Fair Value
107% downsideOvervalued by 107% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.45 Billion |
|---|---|
| Enterprise Value | $4.27 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.8 |
| Beta | 0.12 |
| Outstanding Shares | 76,516,535 |
Return
| Return on Equity | 12.06% |
|---|---|
| Return on Assets | 8.85% |
| Return on Invested Capital | 14.52% |
Valuation & Multiples
| P/E Ratio | 60.41 |
|---|---|
| PEG | 36.71 |
| Price to Sales | 7.17 |
| Price to Book Ratio | 9.22 |
| Enterprise Value to Revenue | 5.66 |
| Enterprise Value to EBIT | 43.98 |
| Enterprise Value to Net Income | 58 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 5, 2026
EPS Estimate
$0.18
Average shareholder expectationRevenue Estimate
$207.12 M
Average shareholder expectationNext Earnings Call
Expected Date
July 28, 2026
EPS Estimate
$0.30
Average shareholder expectationRevenue Estimate
$226.49 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0220▼ 2.12% |
|---|---|
| Total Calls | 1,066,700▼ 31.84% |
| Total Puts | 23,500▼ 65.24% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 61.19%▲ 2.83% |
|---|---|
| Total Invested | $2.18B▲ 23.15% |
| Investors Holding | 234▲ 7.00% |
ESG Score
No data